Join us at Biomarkers US 2023

October 12-13, 2023 | Hilton San Diego Bayfront | San Diego, CA

We look forward to participating in this important industry event and being part of the program sharing new innovations in biomarker discovery and development. If you’ve been wanting to learn more about discovery metabolomics and the applications of small molecule biomarkers in drug development – across many disease areas and pipeline phases – then we invite you to meet up with our team during the conference in the following ways:

Join our session: “Dynamic Small Molecule Biomarkers to Improve Patient Selection in Clinical Trials”

October 12, 2023 | 12:05pm PT | ADD TO CALENDAR

Sapient’s Founder and CEO, Dr. Mo Jain, will present data and real-world case reports on:

• Limitations of genomics and polygenic risk scores as a predictor of disease and treatment response

• The use of dynamic small molecule biomarkers to identify responders vs. non-responders

• Emerging mass spectrometry technologies to enable rapid identification of small molecule biomarkers at an entirely new scale

• Case report examples of how these technologies have been applied to discover biomarkers to improve patient selection and enrich for responders as part of a clinical trial strategy

Visit Sapient at Booth #3

Stop by our table during the event to meet with our attending team members, including Dr. Jain as well as Dr. Tanya Nguyen, Head of Scientific Operations, and Nate Saksa, Discovery Associate.

Pre-schedule an on-site meeting

Have specific questions or potential programs you’d like to discuss? We would love to talk through your needs and how we can partner together to accelerate your drug discovery and development efforts. Use this link to set up a 1-on-1 meeting time during Biomarkers US.